GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sartorius SRT.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

229.00

+0.88%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€3.54bn

FY2016FY2025

Net income

€154.9m

FY2016FY2025

Free cash flow

€214.1m

FY2016FY2025

Shareholders' equity

€2.71bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€3.54bn€3.38bn€3.40bn€4.17bn€3.45bn€2.34bn€1.83bn€1.57bn€1.40bn€1.30bn
Gross profit€1.64bn€1.52bn€1.57bn€2.20bn€1.84bn€1.21bn€941.2m€803.6m€706.8m€631.8m
Research and development€174.0m€196.8m€170.8m€177.8m€139.9m€108.4m€95.6m€78.2m€68.8m€59.4m
Operating income€651.4m€437.2m€543.2m€1.16bn€735.8m€523.5m€355.9m€300.6m€263.0m€247.7m
Net income€154.9m€84.0m€205.2m€913.1m€427.0m€321.5m€218.7m€141.3m€114.7m€102.9m
Diluted earnings per share2.241.223.0013.356.234.683.202.071.661.49

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€9.72bn€10.10bn€9.76bn€6.98bn€5.70bn€4.70bn€2.84bn€2.53bn€2.30bn€1.75bn
Cash and short-term investments€551.8m€828.7m€394.2m€196.8m€361.0m€217.6m€65.9m€67.3m€74.7m€72.1m
Total liabilities€5.85bn€6.21bn€7.00bn€4.32bn€3.98bn€3.30bn€1.76bn€1.55bn€1.49bn€1.02bn
Debt€4.28bn€4.56bn€5.31bn€2.54bn€2.08bn€2.09bn€1.07bn€1.00bn€999.2m€611.4m
Shareholders' equity€2.71bn€2.76bn€2.07bn€1.99bn€1.26bn€1.05bn€810.4m€740.6m€617.8m€579.7m
Shares outstanding69m69m68m68m69m69m68m68m69m69m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€656.0m€976.2m€853.6m€734.2m€865.8m€511.5m€377.2m€244.5m€206.5m€170.4m
Capital spending−€441.9m−€409.9m−€559.7m−€522.6m−€407.2m−€240.3m−€225.6m−€233.2m−€197.1m−€148.8m
Free cash flow€214.1m€566.3m€293.9m€211.6m€458.6m€271.3m€151.6m€11.3m€9.4m€21.7m
Dividends paid−€50.7m−€50.7m−€98.2m−€85.9m−€48.2m−€24.3m−€42.1m−€34.5m−€31.1m−€34.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€911.8m€899.1m€927.6m€843.2m€884.3m€883.0m€906.8m€793.6m
Gross profit€433.1m€414.5m€396.4m€393.2m€416.2m€431.0m€394.6m€345.1m
Operating income€177.9m€151.0m€156.7m€147.7m€132.0m€175.4m€29.5m€68.2m
Net income€41.2m€56.2m€30.2m€43.8m€32.5m€48.5m€44.4m€8.3m
Diluted earnings per share0.600.810.440.630.470.700.640.12
Cash from operations€175.0m€176.0m€307.0m€74.0m€150.0m€139.0m€363.0m€266.0m
Capital spending−€83.0m−€77.0m−€136.0m−€143.0m−€85.0m−€76.0m−€90.0m−€91.0m
Free cash flow€92.0m€99.0m€171.0m−€69.0m€65.0m€63.0m€273.0m€175.0m
Total assets€9.60bn€9.87bn€9.72bn€9.61bn€10.03bn€10.11bn€10.10bn€9.79bn
Cash and short-term investments€306.9m€573.8m€541.4m€389.9m€871.8m€877.1m€828.7m€579.2m
Debt€3.89bn€4.13bn€4.32bn€4.27bn€4.66bn€4.63bn€4.42bn€4.39bn
Shareholders' equity€2.82bn€2.73bn€2.71bn€2.67bn€2.66bn€2.71bn€2.76bn€2.67bn

Financial ratios

Data as of 1 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin46.3%45.1%46.1%52.6%53.3%51.6%
Operating margin18.4%12.9%16.0%27.9%21.3%22.4%
Net margin4.4%2.5%6.0%21.9%12.4%13.8%
Return on equity5.7%3.0%9.9%45.9%33.9%30.7%
Return on assets1.6%0.8%2.1%13.1%7.5%6.8%
Free cash flow yield7.8%9.8%10.1%9.0%9.1%5.4%
Revenue growth4.7%-0.4%-18.7%21.0%47.7%27.8%
Earnings growth84.4%-59.1%-77.5%113.9%32.8%47.0%
Current ratio0.90x1.46x1.47x1.12x1.16x1.39x
Debt to equity1.52x1.60x2.51x1.22x1.58x1.93x
Equity ratio27.9%27.4%21.2%28.5%22.1%22.3%
Interest coverage3.29x2.13x3.46x17.14x16.16x9.12x
R&D as a share of sales4.9%5.8%5.0%4.3%4.1%4.6%
Buybacks as a share of market value-0.0%-0.9%0.0%0.2%0.2%-0.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.4%8.7%12.2%
Operating income-17.6%4.5%11.9%
Net income-44.6%-13.6%2.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin45.7%47.8%49.2%49.5%
Operating margin15.7%19.3%20.0%19.8%
Net margin3.5%9.4%10.4%10.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings85.5141.788.325.180.173.754.746.345.448.8
Price to sales3.73.55.35.59.910.26.54.23.73.9

Dividends and splits

Per share, in the currency the company pays

Paid for 27 years. Last went ex-dividend on 27 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.731.520.731.431.250.700.350.61
  • 4-for-1 split · 13 Jun 2016
  • 26-for-1 split · 13 Dec 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.